Pancreatic Cancer Research

ResearcherUniversity of Maryland, BaltimoreNo recent work listed

Rong Chen

Matched on ORCID iD 0000-0002-5288-2733; OpenAlex author ID A5100419034. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 8

  1. Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer. First author DOI 10.3389/fonc.2023.1259070↗
  2. Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s11596-022-2535-2↗
  3. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00261-020-02506-6↗
  4. Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fonc.2020.01618↗
  5. Pancreatic Ductal Adenocarcinoma: Machine Learning-Based Quantitative Computed Tomography Texture Analysis For Prediction Of Histopathological Grade. Last author DOI 10.2147/cmar.s218414↗
  6. Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images. Co-author DOI 10.3389/fonc.2019.01171↗
  7. Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Co-author DOI 10.1088/1478-3975/11/6/065002↗
  8. Transport properties of pancreatic cancer describe gemcitabine delivery and response. Co-author DOI 10.1172/jci73455↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuai Ren · 6 shared papers, 2019–2023 · strength 0.93
  2. Zhongqiu Wang · 6 shared papers, 2019–2023 · strength 0.93
  3. Rui Zhao · 4 shared papers, 2019–2022 · strength 0.51
  4. Wenli Qiu · 3 shared papers, 2019–2020 · strength 0.31
  5. Kai Guo · 2 shared papers, 2020 · strength 0.23
  6. Xiao Chen · 2 shared papers, 2019 · strength 0.20
  7. Yingying Cao · 1 shared paper, 2020 · strength 0.11
  8. Jingjing Zhang · 1 shared paper, 2019 · strength 0.09
  9. Ryan Michael Thomas · 2 shared papers, 2014 · strength 0.06
  10. Milind M. Javle · 2 shared papers, 2014 · strength 0.06
  11. Matthew H. G. Katz · 2 shared papers, 2014 · strength 0.06
  12. Mauro Ferrari B · 2 shared papers, 2014 · strength 0.06
  13. James L. Abbruzzese · 2 shared papers, 2014 · strength 0.06
  14. Eric Peter Tamm · 2 shared papers, 2014 · strength 0.06
  15. Huamin Wang · 2 shared papers, 2014 · strength 0.06
  16. Ya’an Kang · 2 shared papers, 2014 · strength 0.06
  17. Deyali Chatterjee · 2 shared papers, 2014 · strength 0.06
  18. Robert A. Wolff · 2 shared papers, 2014 · strength 0.06
  19. Vijaya N. R. Gottumukkala · 2 shared papers, 2014 · strength 0.06
  20. Haifa Shen · 2 shared papers, 2014 · strength 0.06
  21. Priya Bhosale · 2 shared papers, 2014 · strength 0.06
  22. Mark Joseph Truty · 2 shared papers, 2014 · strength 0.06
  23. Jason B. Fleming · 2 shared papers, 2014 · strength 0.06
  24. Eugene Jon Koay · 2 shared papers, 2014 · strength 0.06
  25. Gauri Rajani Varadhachary · 2 shared papers, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.